Pentraxin 3 mediates inflammation and adipogenesis in Graves’ orbitopathy pathogenesis

in Journal of Molecular Endocrinology
Authors:
Min Seok Kim Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by Min Seok Kim in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0009-0001-0567-3875
,
Hyun Young Park Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by Hyun Young Park in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-1673-6392
,
Soo Hyun Choi Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by Soo Hyun Choi in
Current site
Google Scholar
PubMed
Close
,
Eun-Ju Chang Department of Anatomy and Cell Biology, Cellular Dysfunction Research Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Eun-Ju Chang in
Current site
Google Scholar
PubMed
Close
,
JaeSang Ko Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by JaeSang Ko in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-3011-7213
, and
Jin Sook Yoon Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by Jin Sook Yoon in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-8751-9467

Correspondence should be addressed to J S Yoon: yoonjs@yuhs.ac

*(M S Kim and H Y Park contributed equally as co-first authors)

Restricted access
Rent on DeepDyve

Sign up for journal news

Pentraxin 3 (PTX3) is a prototypic humoral soluble pattern-recognition molecule known to function in immunity-related inflammation. Given the lack of information on the precise functions of PTX3 in the pathogenesis of Graves’ orbitopathy (GO), this study investigated the role of PTX3 in the inflammation and adipogenesis mechanisms of GO. We first compared the PTX3 expression between orbital tissues from patients with GO and normal controls using real-time PCR, which estimated significantly higher PTX3 transcript levels in the GO tissues than in the normal tissues. In addition, PTX3 production was markedly increased upon interleukin (IL)-1β and adipogenic stimulation. We then evaluated the effects of silencing PTX3 in primary orbital fibroblast cultures by analyzing the expression levels of pro-inflammatory cytokines, adipogenesis-related proteins, and downstream transcription factors in cells transfected with or without small interfering RNA against PTX3, using western blot. Silencing PTX3 attenuated the IL-1β-induced secretion of pro-inflammatory cytokines, including IL-6, IL-8, monocyte chemotactic protein-1, intercellular adhesion molecule-1, and cyclooxygenase-2, and suppressed the IL-1β-mediated activation of p38 kinase, nuclear factor-κB, and extracellular signal-regulated kinase. Moreover, PTX3 knockdown suppressed adipogenic differentiation, as assessed using Oil Red O staining, as well as the expression of adipogenesis-associated transcription factors including peroxisome proliferator-activated receptor-γ, CCAAT/enhancer-binding proteins α and β, adipocyte protein 2, adiponectin, and leptin. Thus, this study suggests that PTX3 plays a significant role in the pathogenesis of GO and may serve as a novel therapeutic target for the condition.

 

  • Collapse
  • Expand
  • Abderrahim-Ferkoune A, Bezy O, Chiellini C, Maffei M, Grimaldi P, Bonino F, Moustaid-Moussa N, Pasqualini F, Mantovani A, Ailhaud G, et al.2003 Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. Journal of Lipid Research 44 9941000. (https://doi.org/10.1194/jlr.M200382-JLR200)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Alles VV, Bottazzi B, Peri G, Golay J, Introna M & & Mantovani A 1994 Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 84 34833493.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Assandri R, Monari M, Colombo A, Dossi A & & Montanelli A 2015 Pentraxin 3 plasma levels and disease activity in systemic lupus erythematosus. Autoimmune Diseases 2015 354014. (https://doi.org/10.1155/2015/354014)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Bahn RS 2010 Graves’ ophthalmopathy. New England Journal of Medicine 362 726738. (https://doi.org/10.1056/NEJMra0905750)

  • Bonacina F, Moregola A, Porte R, Baragetti A, Bonavita E, Salatin A, Grigore L, Pellegatta F, Molgora M, Sironi M, et al.2019 Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity. Cardiovascular Research 115 18611872. (https://doi.org/10.1093/cvr/cvz068)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Bottazzi B, Garlanda C, Cotena A, Moalli F, Jaillon S, Deban L & & Mantovani A 2009 The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunological Reviews 227 918. (https://doi.org/10.1111/j.1600-065X.2008.00719.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D’Ettorre C, Gianazza E, et al.1997 Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. Journal of Biological Chemistry 272 3281732823. (https://doi.org/10.1074/jbc.272.52.32817)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Breviario F, d’Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M, et al.1992 Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. Journal of Biological Chemistry 267 2219022197. (https://doi.org/10.1016/S0021-9258(1841653-5)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Cheng CW, Fang WF, Tang KT & & Lin JD 2021 Serum interferon levels associated with the disease activity in women with overt Graves’ disease. Cytokine 138 155353. (https://doi.org/10.1016/j.cyto.2020.155353)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Chiari D, Pirali B, Perano V, Leone R, Mantovani A & & Bottazzi B 2023 The crossroad between autoimmune disorder, tissue remodeling and cancer of the thyroid: the long pentraxin 3 (PTX3). Frontiers in Endocrinology 14 1146017. (https://doi.org/10.3389/fendo.2023.1146017)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Cieślik P & & Hrycek A 2012 Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity 45 119128. (https://doi.org/10.3109/08916934.2011.611549)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, Zambelli V, Cuccovillo I, Bastone A, Gobbi M, Valentino S, et al.2010 Regulation of leukocyte recruitment by the long pentraxin PTX3. Nature Immunology 11 328334. (https://doi.org/10.1038/ni.1854)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Deniz T, Kizilgul M, Uzunlulu M, Oguz A & & Isbilen B 2014 Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis. Acta Reumatológica Portuguesa 39 137142.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Doni A, Mantovani A, Bottazzi B & & Russo RC 2021 PTX3 regulation of inflammation, hemostatic response, tissue repair, and resolution of fibrosis favors a role in limiting idiopathic pulmonary fibrosis. Frontiers in Immunology 12 676702. (https://doi.org/10.3389/fimmu.2021.676702)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, et al.2020 Teprotumumab for the treatment of active thyroid eye disease. New England Journal of Medicine 382 341352. (https://doi.org/10.1056/NEJMoa1910434)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Garlanda C, Bottazzi B, Bastone A & & Mantovani A 2005 Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annual Review of Immunology 23 337366. (https://doi.org/10.1146/annurev.immunol.23.021704.115756)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Garlanda C, Bottazzi B, Moalli F, Deban L, Molla F, Latini R & & Mantovani A 2011 Pentraxins and atherosclerosis: the role of PTX3. Current Pharmaceutical Design 17 3846. (https://doi.org/10.2174/138161211795049750)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Gatto M, Ghirardello A, Luisetto R, Bassi N, Fedrigo M, Valente M, Valentino S, Del Prete D, Punzi L & & Doria A 2016 Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. Journal of Autoimmunity 74 208216. (https://doi.org/10.1016/j.jaut.2016.07.002)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Gillespie EF, Raychaudhuri N, Papageorgiou KI, Atkins SJ, Lu Y, Charara LK, Mester T, Smith TJ & & Douglas RS 2012 Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. Investigative Ophthalmology and Visual Science 53 77467753. (https://doi.org/10.1167/iovs.12-9861)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Goodman AR, Levy DE, Reis LF & & Vilcek J 2000 Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages. Journal of Leukocyte Biology 67 387395. (https://doi.org/10.1002/jlb.67.3.387)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Gritti G, Raimondi F, Bottazzi B, Ripamonti D, Riva I, Landi F, Alborghetti L, Frigeni M, Damiani M, Micò C, et al.2021 Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia 35 27102714. (https://doi.org/10.1038/s41375-021-01299-x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Guo H, Qiu X, Deis J, Lin TY & & Chen X 2020 Pentraxin 3 deficiency exacerbates lipopolysaccharide-induced inflammation in adipose tissue. International Journal of Obesity 44 525538. (https://doi.org/10.1038/s41366-019-0402-4)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Ham HJ, Lee YS, Yun J, Son DJ, Lee HP, Han SB & & Hong JT 2020 K284-6111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of Chitinase-3-like 1 regulating ERK-dependent PTX3 pathway. Journal of Neuroinflammation 17 350. (https://doi.org/10.1186/s12974-020-02022-w)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Hsiao YW, Chi JY, Li CF, Chen LY, Chen YT, Liang HY, Lo YC, Hong JY, Chuu CP, Hung LY, et al.2022 Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers. Clinical and Translational Medicine 12 e724. (https://doi.org/10.1002/ctm2.724)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Huang Y, Fang S, Li D, Zhou H, Li B & & Fan X 2019 The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy. Eye 33 176182. (https://doi.org/10.1038/s41433-018-0279-9)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Hwang N, Kwon MY, Woo JM & & Chung SW 2019 Oxidative stress-induced Pentraxin 3 expression human retinal pigment epithelial cells is involved in the pathogenesis of age-related macular degeneration. International Journal of Molecular Sciences 20 6028. (https://doi.org/10.3390/ijms20236028)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Inforzato A, Baldock C, Jowitt TA, Holmes DF, Lindstedt R, Marcellini M, Rivieccio V, Briggs DC, Kadler KE, Verdoliva A, et al.2010 The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. Journal of Biological Chemistry 285 1768117692. (https://doi.org/10.1074/jbc.M109.085639)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Ko J, Kim JY, Lee EJ & & Yoon JS 2018 Inhibitory effect of idelalisib, a selective phosphatidylinositol 3-kinase δ inhibitor, on adipogenesis in an in vitro model of Graves’ orbitopathy. Investigative Ophthalmology and Visual Science 59 44774485. (https://doi.org/10.1167/iovs.18-24509)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Krieger CC, Neumann S & & Gershengorn MC 2020 TSH/IGF1 receptor crosstalk: mechanism and clinical implications. Pharmacology and Therapeutics 209 107502. (https://doi.org/10.1016/j.pharmthera.2020.107502)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Lech M, Römmele C, Gröbmayr R, Eka Susanti H, Kulkarni OP, Wang S, Gröne HJ, Uhl B, Reichel C, Krombach F, et al.2013 Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury. Kidney International 83 647661. (https://doi.org/10.1038/ki.2012.463)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Lehmann GM, Feldon SE, Smith TJ & & Phipps RP 2008 Immune mechanisms in thyroid eye disease. Thyroid 18 959965. (https://doi.org/10.1089/thy.2007.0407)

  • Mantovani A, Garlanda C, Doni A & & Bottazzi B 2008 Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. Journal of Clinical Immunology 28 113. (https://doi.org/10.1007/s10875-007-9126-7)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Mou P, Chen Z, Jiang L, Cheng J & & Wei R 2018 PTX3: a potential biomarker in thyroid associated ophthalmopathy. BioMed Research International 2018 5961974. (https://doi.org/10.1155/2018/5961974)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Planck T, Parikh H, Brorson H, Mårtensson T, Åsman P, Groop L, Hallengren B & & Lantz M 2011 Gene expression in Graves’ ophthalmopathy and arm lymphedema: similarities and differences. Thyroid 21 663674. (https://doi.org/10.1089/thy.2010.0217)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Qi S, Zhao F, Li Z, Liang F & & Yu S 2020 Silencing of PTX3 alleviates LPS-induced inflammatory pain by regulating TLR4/NF-κB signaling pathway in mice. Bioscience Reports 40 BSR20194208. (https://doi.org/10.1042/BSR20194208)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Sharma A, Khan R, Gupta N, Sharma A, Zaheer MS, Abbas M & & Khan SA 2018 Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis. Clinica Chimica Acta 480 6570. (https://doi.org/10.1016/j.cca.2018.01.035)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Shin MK, Choi B, Kim EY, Park JE, Hwang ES, Lee HJ, Kim MK, Kim JE, Kim SW & & Chang EJ 2018 Elevated Pentraxin 3 in obese adipose tissue promotes adipogenic differentiation by activating neuropeptide Y signaling. Frontiers in Immunology 9 1790. (https://doi.org/10.3389/fimmu.2018.01790)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Skare TL, Nisihara R, Ramos GP, Utiyama SRR & & Messias-Reason I 2015 Pentraxin-3 levels in systemic lupus erythematosus: association with cumulative damage but not with disease activity. Joint Bone Spine 82 466467. (https://doi.org/10.1016/j.jbspin.2014.09.003)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, et al.2017 Teprotumumab for thyroid-associated ophthalmopathy. New England Journal of Medicine 376 17481761. (https://doi.org/10.1056/NEJMoa1614949)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Tong M, Xiong Y, Zhu C, Xu H, Zheng Q, Hu C, Jiang Y, Zou L, Xiao X, Chen F, et al.2021 Elevated serum Pentraxin-3 levels is positively correlated to disease severity and coagulopathy in COVID-19 patients. Mediterranean Journal of Hematology and Infectious Diseases 13 e2021015. (https://doi.org/10.4084/MJHID.2021.015)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Valyasevi RW, Erickson DZ, Harteneck DA, Dutton CM, Heufelder AE, Jyonouchi SC & & Bahn RS 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. Journal of Clinical Endocrinology and Metabolism 84 25572562. (https://doi.org/10.1210/jcem.84.7.5838)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Wang H, Atkins SJ, Fernando R, Wei RL & & Smith TJ 2015 Pentraxin-3 is a TSH-inducible protein in human fibrocytes and orbital fibroblasts. Endocrinology 156 43364344. (https://doi.org/10.1210/en.2015-1399)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Yoon JS & & Kikkawa DO 2022 Thyroid eye disease: from pathogenesis to targeted therapies. Taiwan Journal of Ophthalmology 12 311. (https://doi.org/10.4103/tjo.tjo_51_21)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Yoon JS, Lee HJ, Choi SH, Chang EJ, Lee SY & & Lee EJ 2011 Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves’ orbitopathy. PLoS One 6 e26261. (https://doi.org/10.1371/journal.pone.0026261)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Zhang H, Wang Y, Zhao Y, Liu T, Wang Z, Zhang N, Dai Z, Wu W, Cao H, Feng S, et al.2022 PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma. CNS Neuroscience and Therapeutics 28 17481766. (https://doi.org/10.1111/cns.13913)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Zhao LQ, Wei RL, Cheng JW, Cai JP & & Li Y 2010 The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves’ ophthalmopathy. Investigative Ophthalmology and Visual Science 51 46524660. (https://doi.org/10.1167/iovs.09-3789)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Zineldeen DH, Keshk WA, Ghazy AH & & El-Barbary AM 2016 Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients. Annals of Clinical Biochemistry 53 240251. (https://doi.org/10.1177/0004563215578190)

    • PubMed
    • Search Google Scholar
    • Export Citation